Amlodipine Besylate API Witnesses a Declining Price Trend as October Approaches
Amlodipine Besylate API Witnesses a Declining Price Trend as October Approaches

Amlodipine Besylate API Witnesses a Declining Price Trend as October Approaches

  • 13-Oct-2022 3:58 PM
  • Journalist: Peter Schmidt

The price trend of Amlodipine Besylate API in the European and Asian markets enters the fourth quarter of 2022 on a declining note. However, dull market dynamics are observed, which brings up by the weak demand from downstream industries. Moreover, the high inflation rate in Europe hurts the overall prices of Amlodipine Besylate API due to drops in consumer purchasing activities.

As per the data, Amlodipine Besylate API prices have dropped by more than 3% in Germany. The primary factor for the ultimate decrease in price is the adequate availability of the product in the German market coupled with bearish demand from downstream pharmaceutical and healthcare industries. The Amlodipine Besylate API price plunge also initiates by dwindling offtakes from the domestic market, causing muted buying activities. Also, imports from Asia-Pacific have become normal as prices drop. In the German market, Amlodipine Besylate API CFR Hamburg prices are currently hovering between USD 53700/MT and USD 57510/MT and are likely to settle around USD 54200/MT by the end of October.

At the same time, the Chinese economic outlook has lowered further following the Golden Week holiday entering October. Also, with a decrease in temperature, factories have resumed their production and maintenance. The shortage of Amlodipine Besylate API supply caused by high-temperature maintenance has been gradually reduced, and the market supply has returned to normal. Therefore, manufacturers in the Chinese market have sufficient inventories of Amlodipine Besylate API to cater to the overall demand. All these factors influence the negative movement for Amlodipine Besylate API. Hence, as a result, the Amlodipine Besylate API price has been reduced by near about 3.5% in China.

While according to ChemAnalyst, it is estimated that Amlodipine Besylate API will likely get stable in European and Asian markets in the upcoming month due to anticipation of steady demand fundamentals from downstream industries on the back of adequate inventories among domestic merchants.

Related News

March Sees Global Amlodipine Besylate Price Drop: Insights Revealed
  • 05-Apr-2024 3:45 PM
  • Journalist: Harold Finch
Global Amlodipine Besylate Prices Surge in March as Demand Peaks and Supplies Dwindle
  • 14-Mar-2024 3:18 PM
  • Journalist: Emilia Jackson
Pfizer Seals $43 Billion Seagen Acquisition, Elevating Cancer Treatment Standards
  • 29-Jan-2024 5:15 PM
  • Journalist: Henry Locke
Fluctuating Market Trends Lead to a Dip in Amlodipine Besylate Prices in Germany
  • 04-Jan-2024 5:11 PM
  • Journalist: Nina Jiang